British consumer healthcare group Haleon lowered its annual revenue growth forecast to about 3.5% on Thursday after ...

GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

A new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 ...

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

If successful, M72 might be the first new TB vaccine in more than a century to meet the WHO's target product profile, ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.

GlaxoSmithKline downgraded full-year earnings expectations, as its second-quarter profit was hit by currency moves, weak sales of its respiratory drugs and the continuing bribery investigation in ...

Pharmaceutical comipany GlaxoSmithKline is under scrutiny following the death of children in Argentina. Parents believe that the experimental vaccines may be the cause of infant deaths.